FacultyResearch Focus
Thomas F. Patterson, M.D.
Professor of Medicine
Division Chief, Infectious Diseases
Vice Chair for Faculty Development
Patterson@uthscsa.edu
Animal Models of Invasive Fungal Infections
Antifungal Susceptibility Testing
Antifungal Therapy
Clinical Mycology
Fungal Diagnostics
Sunil K. Ahuja, M.D., M.S.
Professor of Medicine
President's Council/Dielmann Chair for Excellence in Medical Research
Director, Research Enhancement Programs, VPR Office
Ahujas@uthscsa.edu
P4 (prediction, prevention, personalization, and participatory) medicine
Immunologic, genetic, and epigenetic determinants of immunologic diseases such as asthma, allergy, HIV, and COVID-19
Age independent prediction of acute COVID-19 outcomes and vaccine responses
Development of metrics of immunologic health that predict immunity-dependent outcomes, including lifespan
Gregory M. Anstead, M.D., Ph.D.
Professor/Clinical
Anstead@uthscsa.edu
Vector-Borne and Parasitic Infections
Historical Epidemiology of Infectious Diseases
MRSA Treatment
HIV Clinical Care
Endemic Mycoses
Jason Bowling, M.D.
Associate Professor/Clinical
Director of Hospital Epidemiology, UHS
Bowling@uthscsa.edu
The effect of antibiotic utilization on antibiotic resistance
Health care associated infections
Antibiotic stewardship
Outpatient parenteral antimicrobial therapy
Jose A. Cadena Zuluaga, M.D.
Associate Professor/Clinical
Cadenazuluag@uthscsa.edu
VA Cooperative studies: Optial Treatment for Recurrent Clostridium Difficile Infection (OpTION)
Summit
Predictors of CDI and Healthy Aging Outcomes in a prospective cohort of Veterans
VA Cooperative studies: Investigation of Rifampin to reduce pedal amputations for osteomyelitis in diabetics (VA INTREPID)
Heta Javeri, M.D., MPH
Assistant Professor/Clinical
Fellowship Program Director
Javeri@uthscsa.edu
OPAT Quality Improvement Project
Case Series
NTM Review – Retrospective review of cases of non-tuberculous mycobacterial
Senlin Li, M.D., M.S.
Professor/Research
Lis1@uthscsa.edu
Novel/non-toxic hematopoietic and immune compartment replacement/rejuvenation
Hematopoietic stem cell transplantation-based immune cell/macrophage/microglia-mediated neurotrophic factor gene therapy for neurodegenerative diseases such as Parkinson’s and Alzheimer’s
Hematopoietic stem cell transplantation-based immune cell/macrophage-mediated gene therapy for atherosclerosis
Hematopoietic stem cell transplantation-based genetic engineering for potential eradiation of HIV or induction of long-term remission without requiring ongoing antiretroviral therapy
Jan E. Patterson, M.D., M.S.
Professor of Medicine
Associate Dean, Quality & Lifelong Learning
Pattersonj@uthscsa.edu
Quality Improvement and Patient Safety
Opportunities for participation in QI inter-professional education
Integrative Medicine
Use of other integrative therapies in clinical medicine
COVID Clinical Research
ID Emergency Preparedness
Ruth C. Serrano Pinilla, M.D.
Assistant Professor/Clinical
Serranopinil@uthscsa.edu
Access to care for disadvantaged population, community-based projects
Perceptions of HIV risk and knowledge of HIV prevention strategies among minorities recently diagnosed with HIV infection in South Texas
Research Activity and Community Engagement to Screen, Treat and Organize Prevention for Hepatitis C (HCV) – (RACE to STOP HCV)
Barbara Taylor, M.D., M.S.
Associate Professor of Medicine
Assistant Dean, MD/MPH Program
Adjunct Faculty, School of Public Health
Taylorb4@uthscsa.edu
Improving health outcomes in underserved populations living with HIV
Improving engagement in HIV care in San Antonio
Determining the impact of chronic comorbidities in the context of HIV as a chronic illness
HIV vaccine trials
COVID-19 vaccine trials, clinical trials, and observational studies
Elizabeth A. Walter, M.D.
Professor/Clinical
Waltere@uthscsa.edu
Antimicrobial Stewardship